Mefoxin

In the US, Mefoxin (cefoxitin systemic) is a member of the drug class second generation cephalosporins and is used to treat Aspiration Pneumonia, Bone infection, Cesarean Section, Cholecystitis, Deep Neck Infection, Endometritis, Gonococcal Infection - Uncomplicated, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Septicemia, Skin and Structure Infection, Skin Infection, Surgical Prophylaxis and Urinary Tract Infection.

US matches:

• Mefoxin


• Mefoxin Premixed

Ingredient matches for Mefoxin

Cefoxitin

Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Mefoxin in the following countries:

• Argentina


• Bahrain


• Cyprus


• Egypt


• Guyana


• Iran


• Iraq


• Ireland


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Oman


• Qatar


• Saudi Arabia


• Sudan


• Syria


• Taiwan


• United Arab Emirates


• United States


• Yemen

International Drug Name Search